MagForce AG Publishes Financial Year Results 2014 And Operative Highlights

BERLIN & NEVADA--(BUSINESS WIRE)--MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results for the fiscal year ending on December 31, 2014 and operative highlights.

Operative Highlights:

Brain Cancer NanoTherm(TM) Therapy at MagForce AG

Help employers find you! Check out all the jobs and post your resume.